Delivery Order SPE2DB20D1109-SPE2DB25FN98A

Award Date 4/30/25
Potential Completion Date 5/1/25
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 40 mg/0.4 mL auto-injector pens. The contract has a firm fixed price of $2,265.90 and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) 40 mg/0.4 mL pens, a medication used to treat various autoimmune conditions. The contract has a firm fixed price of $1,510.60 and a completion date of April 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) 40 mg/0.4 mL prefilled pens, a biologic medication used to treat various autoimmune conditions. The contract has a firm fixed price of $2,265.90 and a performance period ending on April 28, 2025. This contract is not set aside for any specific business...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira Pen 40 mg/0.8 mls. The contract has a firm fixed price, a ceiling value of $2,033.86, and a performance period ending on May 16, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira Pen 40 mg/0.8 mL medication. The contract has a firm fixed price of $1,353.97 and a performance period extending through May 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS. The contract has a firm fixed price of $2,265.90 and a period of performance through June 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Humira (adalimumab) Pen 40 mg/0.4 mL. The contract has a firm fixed price of $16,552.17 and a completion date of September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 40 mg/0.4 mL auto-injector pens. The contract is a firm fixed-price delivery order with a ceiling value of $3,148.60 and a period of performance through April 18, 2025. This contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract, valued at $2,770.74, is for the supply of Humira (adalimumab) 40 mg/0.4 mL prefilled pens. The contract is a firm fixed-price agreement with a completion date of September 17, 2024. This contract is not designated as a set-aside. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical supplies and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 40 mg/0.4 mL autoinjector pens. The contract has a firm fixed price, a ceiling value of $1,510.60, and a performance period extending through May 12, 2025. It is not set aside for any special designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN98A
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 40 mg/0.4 mL prefilled pens. The contract has a firm fixed price of $2,188.39 and a performance period through May 1, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military and government agency healthcare programs through December 2026. This delivery order contract is one of multiple orders placed under the broader IDC to fulfill federal medical supply requirements.

Generated 8/3/25, 1:21 AM